Anna Dubaniewicz

Prof. Dr. Anna Dubaniewicz


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
JSJonas Christian Schupp
Jonas Christian Schupp
SFSandra Freitag-Wolf
Sandra Freitag-Wolf
EBElena Bargagli
Elena Bargagli
VMVioleta Mihailović-Vučinić
Violeta Mihailović-Vučinić
PRPaola Rottoli
Paola Rottoli
JMJoachim Mueller-Quernheim
Joachim Mueller-Quernheim
Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology. The GenPhenReSa (Genotype–Phenotype Relationship in Sarcoidosis) project represents a European multicentre study to investigate the influence of genotype on disease phenotypes in sarcoidosis.The baseline phenotype module of GenPhenReSa comprised 2163 Caucasian patients with sarcoidosis who were phenotyped at 31 study centres according to a standardised protocol.From this module, we found that patients with acute onset were mainly female, young and of Scadding type I or II. Female patients showed a significantly higher frequency of eye and skin involvement, and complained more of fatigue. Based on multidimensional correspondence analysis and subsequent cluster analysis, patients could be clearly stratified into five distinct, yet undescribed, subgroups according to predominant organ involvement: 1) abdominal organ involvement, 2) ocular–cardiac–cutaneous–central nervous system disease involvement, 3) musculoskeletal–cutaneous involvement, 4) pulmonary and intrathoracic lymph node involvement, and 5) extrapulmonary involvement.These five new clinical phenotypes will be useful to recruit homogenous cohorts in future biomedical studies.

7 September 2014 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
RHRenata Hebel
Renata Hebel
MDMirosława Dubaniewicz-Wybieralska
Mirosława Dubaniewicz-Wybieralska
ADAnna Dubaniewicz
Anna Dubaniewicz
Sarcoidosis (SA) is a granulomatous, multisystem disease of unknown etiology. Most often the disease affects lungs and mediastinal lymph nodes, but it may occur in other organs. Neurosarcoidosis (NS) more commonly occurs with other sarcoidosis forms, in 1 % of cases it involves only nervous system. Symptomatic NS occurs but on autopsy study up to 25 % of cases are confirmed. NS can affect central nervous system: the brain, spinal cord and peripheral nerves, and muscles. The diagnosis of neurosarcoidosis facilitates diagnostic criteria: histopathological, imaging and cerebrospinal fluid examination, and clinical symptoms. At present, there are no set standards for treatment of patients suffering from NS. Early therapy of symptomatic patients is recommended. Corticosteroids still are the first line of treatment for NS patients. In cases of steroids resistance, lack of their effectiveness or existence of contraindication to their use, immunosuppressant treatment is recommended. The latest NS algorithm with immunosuppressive treatment is discussed.

1 September 2006 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
ADAnna Dubaniewicz
Anna Dubaniewicz
MDMirosława Dubaniewicz-Wybieralska
Mirosława Dubaniewicz-Wybieralska
ASAdam Sternau
Adam Sternau
ZZZofia Zwolska
Zofia Zwolska
EIEwa Izycka-Swieszewska
Ewa Izycka-Swieszewska
LZLech Zimnoch
Lech Zimnoch
We demonstrated that not whole Mycobacterium tuberculosis but its particular antigens, hsp70 Mtb , hsp65 Mtb , and hsp16 Mtb , are present in lymph node tissues of patients with sarcoidosis (SA). hsp16 Mtb occurs in the early stage of SA, whereas hsp70 Mtb occurs in stage II of SA. hsp65 Mtb is highly expressed in the capillary vessels in lymph node tissues in patients with SA.

15 January 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ECErik L. Clarke
Erik L. Clarke
ALAbigail P. Lauder
Abigail P. Lauder
CHCasey E. Hofstaedter
Casey E. Hofstaedter
YHYoung Hwang
Young Hwang
AFAyannah S. Fitzgerald
Ayannah S. Fitzgerald
RCRonald G. Collman
Ronald G. Collman
Rationale: The etiology of sarcoidosis is unknown, but microbial agents are suspected as triggers. Objectives: We sought to identify bacterial, fungal, or viral lineages in specimens from patients with sarcoidosis enriched relative to control subjects using metagenomic DNA sequencing. Because DNA from environmental contamination contributes disproportionately to samples with low authentic microbial content, we developed improved methods for filtering environmental contamination. Methods: We analyzed specimens from subjects with sarcoidosis (n = 93), control subjects without sarcoidosis (n = 72), and various environmental controls (n = 150). Sarcoidosis specimens consisted of two independent sets of formalin-fixed, paraffin-embedded lymph node biopsies, BAL, Kveim reagent, and fresh granulomatous spleen from a patient with sarcoidosis. All specimens were analyzed by bacterial 16S and fungal internal transcribed spacer ribosomal RNA gene sequencing. In addition, BAL was analyzed by shotgun sequencing of fractions enriched for viral particles, and Kveim and spleen were subjected to whole-genome shotgun sequencing. Measurements and Main Results: In one tissue set, fungi in the Cladosporiaceae family were enriched in sarcoidosis compared with nonsarcoidosis tissues; in the other tissue set, we detected enrichment of several bacterial lineages in sarcoidosis but not Cladosporiaceae. BAL showed limited enrichment of Aspergillus fungi. Several microbial lineages were detected in Kveim and spleen, including Cladosporium. No microbial lineage was enriched in more than one sample type after correction for multiple comparisons. Conclusions: Metagenomic sequencing revealed enrichment of microbes in single types of sarcoidosis samples but limited concordance across sample types. Statistical analysis accounting for environmental contamination was essential to avoiding false positives.

1 April 2010 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ADAnna Dubaniewicz
Anna Dubaniewicz

1 January 2006 in Tuberculosis
Verified
Journal Article
Closed access
ADAnna Dubaniewicz
Anna Dubaniewicz
SKSusanne Kämpfer
Susanne Kämpfer
MSMahavir Singh
Mahavir Singh